|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 227/06 | |
| C12P 13/04 | |||
| C07C 229/36 |
| (11) | Patento numeris | 3558930 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17832992.6 |
| Europos patento paraiškos padavimo data | 2017-12-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2017/058203 |
| Data | 2017-12-20 |
| (87) | Numeris | WO 2018/116203 |
| Data | 2018-06-28 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2016/1116 | 2016-12-23 | WO |
| (72) |
KLEINBECK-RINIKER, Florian Karl, CH
KAPFERER, Tobias, CH
LAUMEN, Kurt, CH
RUCH, Thomas, CH
SCHLAMA, Thierry, CH
KU, Jie, CN
LI, Yunzhong, CN
PENG, Wei, CN
YANG, Yao, CN
KIM, Hongyong, CN
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | NEW PROCESS FOR EARLY SACUBITRIL INTERMEDIATES |
| NEW PROCESS FOR EARLY SACUBITRIL INTERMEDIATES |